Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr;69(4):278-289.
doi: 10.1007/s00105-018-4153-2.

[Severe skin reactions due to new medications]

[Article in German]
Affiliations
Review

[Severe skin reactions due to new medications]

[Article in German]
M Mockenhaupt et al. Hautarzt. 2018 Apr.

Abstract

Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and a specific form of hypersensitivity syndrome which is nowadays called "drug reaction with eosinophilia and systemic symptoms" (DRESS) are severe, mainly drug-induced skin reactions. Whereas SJS/TEN is considered one reaction entity of different severity, DRESS has to be distinguished from SJS/TEN but also from other severe exanthems due to multiorgan involvement. Although SJS/TEN is generally referred to as drug reaction, in total only about three quarters of the cases are actually caused by drugs. After the clinical diagnosis is made, identification of the potential inducing factor is most important. In case medications are considered as causal, their withdrawal plays a key role in management. In order to identify and withdraw the inducing agent, a detailed and thorough medication history must be obtained. Agents identified or confirmed as inducers of SJS/TEN by pharmacoepidemiological studies are allopurinol, antibacterial sulfonamides, various antiepileptics, nevirapine and nonsteroidal anti-inflammatory drugs of the oxicam-type. Among drugs inducing DRESS are also various antiepileptics, but in addition allopurinol, sulfonamides and minocycline. Some cases of SJS/TEN and DRESS associated with the use of new medication, including targeted therapies and biologicals, have been observed.

Keywords: Drug eruptions; Drug reaction with eosinophilia and systemic symptoms; Medication history; Stevens-Johnson syndrome; Toxic epidermal necrolysis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arch Dermatol. 2002 Aug;138(8):1019-24 - PubMed
    1. J Clin Epidemiol. 1996 Jul;49(7):769-73 - PubMed
    1. J Invest Dermatol. 2005 Apr;124(4):700-3 - PubMed
    1. J Dtsch Dermatol Ges. 2015 Jul;13(7):625-45 - PubMed
    1. J Allergy Clin Immunol. 2011 Mar;127(3 Suppl):S60-6 - PubMed

Substances

LinkOut - more resources